Open Access
- 4 May 2015
- journal article
- Published by European Society of Medicine in Medical Research Archives
- Vol. 2015 (3)
Abstract
Background: We sought to profile Atypical Meningioma in a high-throughput manner to better understand the altered signaling within these tumors and specifically the kinases altered in recurrent atypical meningioma. Kinomic Profiles could be used to identify prognostic biomarkers for responders/non-responders to classify future patients that are unlikely to benefit from current therapies. Directly these results could be used to identify drug-actionable kinase targets as well. Methods: Peptide-substrate microarray kinase activity analysis was conducted with a PamStation®12 analyzing the tyrosine kinome in each tumor kinetically against ~144 target peptides. These data were then analyzed relative to clinical outcome (e.g., tumor recurrence). Results: 3 major clusters of atypical meningiomas were identified with highly variant peptides primarily being targets of EGFR family, ABL, BRK and BMX kinases. Kinomic analysis of recurrent atypical meningiomas indicated patterns of increased phosphorylation of BMX, TYRO3 and FAK substrates as compared to non-recurrent tumors. Conclusion: The atypical meningiomas profiled here exhibited molecular sub-clustering that may have phenotypic corollaries predictive of outcome. Recurrent tumors had increases in kinase activity that may predict resistance to current therapies, and may guide selection of directed therapies. Taken together these data further the understanding of kinomic alteration in atypical meningioma, and the processes that may not only mediate recurrence, but additionally may identify kinase targets for intervention.Keywords
This publication has 18 references indexed in Scilit:
- Atypical meningoma: current management dilemmas and prospective clinical trialsJournal of Neuro-Oncology, 2014
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaNeuro-Oncology, 2014
- Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolinesRadiotherapy and Oncology, 2014
- EGFR, PIK3CA, KRAS and BRAF mutations in meningiomasOncology Letters, 2014
- A Structural Atlas of Kinases Inhibited by Clinically Approved Drugs2014
- Kinase Control of Latent HIV-1 Infection: PIM-1 Kinase as a Major Contributor to HIV-1 ReactivationJournal of Virology, 2014
- Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural FeaturesACS Chemical Biology, 2012
- The role of radiotherapy following gross-total resection of atypical meningiomasJournal of Neurosurgery, 2012
- The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatmentsNeurosurgical Focus, 2011
- THE RECURRENCE OF INTRACRANIAL MENINGIOMAS AFTER SURGICAL TREATMENTJournal of Neurology, Neurosurgery & Psychiatry, 1957